Axxcess Wealth Client App

With the Axxcess Wealth Client App, you can review your portfolio’s performance in great detail and always know where you stand. Track your progress and review your holdings like never before.

Download The App Today!

Don’t miss out on this cutting-edge technology for the wealth management world. No need to find a computer to see how you’re doing, just pull out your phone.

You can download our custom app for iPhone, Android and Windows Phone devices free in your app store today. If you have any questions, feel free to contact us at 858.217.5347.

About Kevin

Kevin Manzo is a Financial Advisor with Axxcess Wealth Management. Kevin’s services are especially valuable to business owners, high-income and high-net-worth professionals and their families. After 12 successful years as a portfolio manager and advisor Kevin has the knowledge and experience to help clients protect what they’ve worked for, enjoy a comfortable retirement, and leave the legacy they choose for their heirs. Along with his Bachelor’s of Business Administration degree in Finance from Chapman University, he also holds the Accredited Investment Fiduciary® credential, signifying his commitment to upholding a high level of fiduciary care for his clients. Based in Fullerton, California, he serves families and business owners throughout North Orange County and Los Angeles. Learn more by connecting with Kevin on LinkedIn.

Self-driving cars, personal gene mapping, smart robots; these are all things of the future, things that our parents couldn’t even imagine when they were children. But now they are becoming a reality. Today’s visionaries are bringing the future into the present. Luckily for you, you don’t have to be a scientist or inventor to be a part of this movement.

As an investor, you can help fund and drive the innovation that is forever changing the world in which we live. You can be a part of the Genomic Revolution, Web x.0, and Industrial Innovation. You can help bring the entire world access to the cloud, make autonomous electric vehicles commonplace, and bring to market effective drugs for fighting terminal illnesses. You can make these life-changing innovations possible.  

Innovation is the key to growth, so by investing in innovative companies you also have great potential for financial returns. Our new “sharing economy” that we have today will increase the utilization of fixed assets, shrinking demand in some sectors while boosting total factor productivity and returns on investing capital.

Investors who understand how disruptive innovation affects the economy and the opportunities that it provides are a step ahead of the rest. They are the ones who will reap the greatest rewards from society’s advancements. And you can be one of them.

If you want to invest in the innovation that is shaping our modern world, we can help. At Axxcess Wealth Management, we have investments available to us that present the best risk-reward opportunities among companies that rely on or benefit from the development of new products or services, technological improvements, and advancements in scientific research. Call us today at 858.217.5347 to see how you can help lead the world through disruptive innovation.

About Kevin

Kevin Manzo is a Financial Advisor with Axxcess Wealth Management. Kevin’s services are especially valuable to business owners, high-income and high-net-worth professionals and their families. After 12 successful years as a portfolio manager and advisor Kevin has the knowledge and experience to help clients protect what they’ve worked for, enjoy a comfortable retirement, and leave the legacy they choose for their heirs. Along with his Bachelor’s of Business Administration degree in Finance from Chapman University, he also holds the Accredited Investment Fiduciary® credential, signifying his commitment to upholding a high level of fiduciary care for his clients. Based in Fullerton, California, he serves families and business owners throughout North Orange County and Los Angeles. Learn more by connecting with Kevin on LinkedIn.

There is a revolution happening that will help you and others live longer, better lives. Your medical care will be more personalized, your medication more potent and precise, and we will finally be able to conquer world hunger. This is not a political or social revolution, but a scientific one.

The genomic revolution has begun and is picking up steam. Already, scientists can sequence the entire human genome, over 20,000 genes, in only a few days and at a cost of only $1,000. Medical care can get truly personal when doctors have access to an actual map of your genes. No longer will care be reactive, but rather proactive and preventive.

This genomic knowledge will also lead to better pharmaceutical developments. Drugs will become more powerful, precise, and profitable — something we will all benefit from.

Beyond just DNA, a greater understanding of proteins, RNA, microbiomes, and other molecules will impact diagnostics and treatments. Stem cells will play an instrumental role in pharmaceuticals and therapy. The genomic revolution is turning the medical world upside down.

Genomic sequencing goes beyond just humans, though. Bacteria, cancer, cantaloupes, and cats can all be sequenced to give us a better understanding of how life thrives, grows, and heals. Not only will human life be transformed in this revolution, but agriculture will as well. Genetically modified crops will become safer and more cost-efficient, bolstering the world’s food supply.

The genomic revolution is providing deeper biological insights and innovations that advance safety and efficacy across the board. The increasingly powerful analytics are eliminating guesswork in everything from genetics to crop planting. Genomic sequencing is revolutionizing the medical industry, and you can be a part of it.

You don’t have to be a scientist or medical doctor to join the revolution that is extending and enhancing the quality of human life. As an investor, you can play a major role as well. You can invest in companies that incorporate technological and scientific developments, improvements, and advancements in genomics into their business.

Not only will investing in human genomics put you on the forefront of a revolution, it can also be very profitable. According to research, genomic sequencing of DNA is expected to grow at a 200% annual growth rate. If you want to be a part of revolutionizing health care, agriculture, and pharmaceuticals through your investments, call us today at 858.217.5347.

About Kevin

Kevin Manzo is a Financial Advisor with Axxcess Wealth Management. Kevin’s services are especially valuable to business owners, high-income and high-net-worth professionals and their families. After 12 successful years as a portfolio manager and advisor Kevin has the knowledge and experience to help clients protect what they’ve worked for, enjoy a comfortable retirement, and leave the legacy they choose for their heirs. Along with his Bachelor’s of Business Administration degree in Finance from Chapman University, he also holds the Accredited Investment Fiduciary® credential, signifying his commitment to upholding a high level of fiduciary care for his clients. Based in Fullerton, California, he serves families and business owners throughout North Orange County and Los Angeles. Learn more by connecting with Kevin on LinkedIn.

As your advisor I am constantly researching ways to grow your money. You won’t see me hosting seminars or steak dinners. I started in the wealth management business from the portfolio management side, so I know how the sauce is made. I am always focused on ways to adapt and innovate for my clients. Former Michigan coach, Bo Schembechler, said it well: “Every day you either get better or you get worse. You never stay the same.”

Innovation is constant in our society and I wanted to add it to portfolios. I researched ways to add exposure to client accounts with this specific theme of innovation.  I came across a management team at www.arkinvest.com that was a perfect fit for what I wanted. Here I found a strategy I could add to client portfolios that was focused on today’s disruptive innovative technologies: robotics, automation, 3D printing, human genomics, Crypto Currency, and artificial intelligence to name a few.

I am proud to announce that the ARK Innovation ETF has been named ETF of the Year as well as being named the Most Innovative ETF Issuer of the Year at the fifth annual ETF.com Awards.

About ARK Innovation

ARK is an actively managed fund focused on capturing the performance of companies involved in “disruptive innovation.” The fund was up an astonishing 87% last year, partially due to it’s allocation to the Bitcoin Investment Trust and the “FANG” stocks, otherwise known as Facebook, Apple, Netflix, and Google/Alphabet. In fact, it was one of our top holdings at Axxcess this past year. The company is driven to capitalize on rapid change in our society and avoid industries and companies likely to be displaced by technological innovation.

If you want to learn more about ARK and its values and vision, check out the full article. If you have any questions about our investment strategy or about how we work to bring growth to your portfolio, contact our office today by calling 858.217.5347.

About Kevin

Kevin Manzo is a Financial Advisor with Axxcess Wealth Management. Kevin’s services are especially valuable to business owners, high-income and high-net-worth professionals and their families. After 12 successful years as a portfolio manager and advisor Kevin has the knowledge and experience to help clients protect what they’ve worked for, enjoy a comfortable retirement, and leave the legacy they choose for their heirs. Along with his Bachelor’s of Business Administration degree in Finance from Chapman University, he also holds the Accredited Investment Fiduciary® credential, signifying his commitment to upholding a high level of fiduciary care for his clients. Based in Fullerton, California, he serves families and business owners throughout North Orange County and Los Angeles. Learn more by connecting with Kevin on LinkedIn.

Athena Global Tactical ETFs Update

With recent market volatility, we have advisors and clients asking about potential position changes to our Global Tactical ETFs portfolio. Tactical managers use different approaches including economic conditions, momentum and valuation. These signals can be short, intermediate or long-term in nature. We use longer-term deep behavioral currents and don’t react to short-term market volatility or drawdowns. The portfolio will typically hold positions for 6-9 months.

We are currently long the S&P 500 and will maintain our position until we re-evaluate our data again in early March. Our market barometers are updated monthly and continue to have expected returns in the normal range of 10% annualized. While the portfolio can move 100% to cash, this usually occurs only in catastrophic scenarios where our barometers sustain dramatic deterioration over time. We rely on our methodology to take the emotions out of the process and this approach has served us well.

The table below provides some perspective on our current S&P 500 position as of 02/09/2018 versus the average of all portfolio positions since inception in September 2010. Our current drawdown is in-line with the average drawdown of our historical positions and that of our benchmark.

 

 

Portfolio performance is Net of Fees.  Portfolio and Benchmark Returns and Drawdowns are not annualized.
^ Benchmark is MSCI ACWI NR Index  View Full Portfolio Disclosures

The current economic, fundamental and behavioral indicators continue to remain solid.  Please reference our monthly Market View.   For suggestions on helping clients, please refer to our Behavioral Advisor Materials.  Sometimes it is just as important to not trade and stay invested through the volatility and drawdowns as it is to exit the market.
PAST PERFORMANCE IS NO GUARANTEE OF FUTURE PERFORMANCE.

Dave Stock
(917) 771-1437
david.stock@athenainvest.com

Steve Bogosian
(314) 562-2223
steve.bogosian@athenainvest.com

The technical details which appear to have created significant selling last week began in the options market after-hours on Friday, February 3rd and are quite extraordinary. For those who are interested in taking a deeper dive, simply Google “what happened to XIV” and you will learn quite a bit about trading volatility. Best we can tell, the unwinding of this particular trade played a significant role in taking what would have just been a bad day in the market to seeing equity indexes enter into “correction territory” – a 10% pullback from recent highs – in 4 days.

Corrections should be seen as a healthy resetting of valuations. They should also remind us to take a look at the risks inherent in any investment strategy – the risk of loss.
Over the past year, Axxcess has been working on the development of a new set of tools to help monitor portfolio risk. The development of these tools has allowed our Advisor’s to “stress test” portfolios against a variety of technical, policy-driven, and economic scenarios.
What is unique about these tools is how they illustrate the potential impact risks can have on both current portfolios and proposed strategies by using historical research and analysis on how economic indicators are correlated. The most important outcome is an understanding of each portfolios’ sensitivity to market movements and the potential sensitivity to loss. Measuring this becomes extremely useful when coupled with an understanding of your sensitivity to loss.
How do we do that? We have created a risk tolerance survey and incorporated a scoring methodology that evaluates your sensitivity to loss. Instead of outputting only a score, our methodology creates a measure of this risk in percentage terms. For example, a conservative investor score translates to a portfolio with a potential loss exposure of 10% or less.
We have highlighted trending scenarios here.
Risk Tolerance is required to be revisited with clients at least annually. A number of things can change your Risk Tolerance Score: job change, income, age, or changes in life circumstances such as the birth of a child, death, divorce, and/or sale or acquisition of a business or real estate, etc.  It is important to make sure that your investment risk tolerance matches your portfolio allocations when selecting your investments.
We have developed a secure, online form that will score and record your responses in lieu of sending out a paper questionnaire.

Looking Ahead

2018 has begun with strong economic growth. GDP as forecasted is expected to rise more 4% in the first quarter. More than 85% of companies in the S and P 500 beat earnings expectations. Wage growth increased 2.9% over the past year.  With corporate tax reform becoming law, the financial health of US businesses should continue to improve.
However, with strong future expectations, comes inflation. With inflation comes higher borrowing costs. Inflation has been benign for several years, and as we see new policy implemented,  both stock and bond markets will need to digest new data. In short, you should expect more volatility in 2018.  Historically the equity markets have been roughly twice as volatile as they were in 2017. Sudden spikes give the financial media a lot of material to focus on. Dealing with volatility can be unnerving at times, but it is a more normal behavior of markets.